Lawlor Mitchell

Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery.

Twenty-four-month outcomes showed sustained IOP reduction with a good safety profile for both groups.

Bruch's Membrane Opening Minimum Rim Width Provides Objective Differentiation between Glaucoma and Nonglaucomatous Optic Neuropathies.

The measurement of MRW-BMO effectively differentiates between NTG and NGON with a high level of sensitivity and specificity.

Patients With Normal Tension Glaucoma Have Relative Sparing of the Relative Afferent Pupillary Defect Compared to Those With Open Angle Glaucoma and Elevated Intraocular Pressure.

Glaucoma patients with NTG have a lesser RAPD for a given level of intereye difference of HVF MD, compared to patients with high IOPs.

Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma.

There was significantly greater complete success at 12 months across all complete success definitions for Trab compared with Xen, whereas the rate of postoperative hypotony was significantly lower in the Xen group.

Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent.

The use of an intraluminal suture stent in PreserFlo MicroShunt surgery reduces the incidence of early hypotony without compromising surgical success.

Long-term comparative outcomes of Hydrus versus iStent inject microinvasive glaucoma surgery implants combined with cataract surgery.

There was no significant difference in surgical success between phaco-Hydrus and phaco-iStent groups at 48 months.

Association Between Prior Selective Laser Trabeculoplasty and Phaco-iStent Inject Efficacy.

In this observational study, prior SLT was associated with an increased risk of failure after phaco-iStent inject surgery.

Impact of Different Intraocular Pressure and Medication Endpoint Criteria on Success Rates in Subconjunctival Minimally Invasive Glaucoma Surgery.

Using different IOP and medication criteria to define success can have a significant influence on the apparent risk of failure, particularly at the 21 mm Hg threshold and when incorporating a minimum 20% IOP reduction from baseline.

Risk Factors for Failure in Minimally Invasive Bleb Surgery: A Systematic Review.

This review identified demographic and preoperative factors associated with MIBS failure, especially non-White ethnicity and reduced/no MMC use.

Registry-based randomised controlled trials in glaucoma: the time is right?

Longitudinal outcomes of iStent inject with cataract surgery compared with cataract surgery alone: real-world data from the Fight Glaucoma Blindness registry.

Real-world outcomes from the FGB registry at 12 months show that phacoemulsification combined with iStent inject has a higher efficacy and reduced need for secondary IOP-lowering surgery compared with phacoemulsification alone.

Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry.

The Xen 45 gel stent implant offers acceptable long-term efficacy for the treatment of open-angle glaucoma.